
Fermenta Biotech has announced a board meeting on August 11, 2026, which approved the financial results for the quarter ended June 30, 2026. Standalone revenue was ₹111.84 Cr, profit ₹14.99 Cr. Consolidated revenue reached ₹121.82 Cr, profit ₹9.53 Cr. The company also reversed a ₹2.05 Cr inventory provision and granted...
Fermenta Biotech Limited's long-term bank facilities of ₹166.73 Cr have been upgraded by CARE Ratings to CARE BBB+ (Stable) from CARE BBB (Stable). Short-term facilities of ₹6.25 Cr are now rated CARE A2. This upgrade reflects positive developments in the company's credit profile.